Achilles Therapeutics (ACHL) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Achilles Therapeutics

NASDAQ: ACHL · Real-Time Price · USD
1.48
0.00 (0.00%)
At close: Mar 20, 2025, 3:59 PM

Achilles Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
131.54M 173.34M 266.32M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
33K 33K 33K
Other Long-Term Assets
2.21M 3.05M 3.54M
Receivables
10.35M 16M 11.17M
Inventory
n/a 4.62M 5.13M
Other Current Assets
1.98M 2.62M 2.12M
Total Current Assets
145.63M 196.58M 284.75M
Property-Plant & Equipment
13.54M 20.48M 28.79M
Goodwill & Intangibles
n/a -33K -33K
Total Long-Term Assets
15.82M 23.78M 32.36M
Total Assets
161.46M 220.36M 317.11M
Account Payables
5.63M 5.19M 3.72M
Deferred Revenue
n/a n/a 9.64M
Short-Term Debt
n/a n/a n/a
Other Current Liabilities
965K 1.75M 1.98M
Total Current Liabilities
17M 17.99M 19.11M
Long-Term Debt
n/a n/a n/a
Other Long-Term Liabilities
1.01M 933K 691K
Total Long-Term Liabilities
2.09M 5.32M 8.47M
Total Liabilities
19.09M 23.31M 27.58M
Total Debt
4.62M 8.58M 12.26M
Book Value
142.37M 197.04M 289.53M
Book Value Per Share
3.56 5.03 10.10
Common Stock
182K 54K 54K
Retained Earnings
-259.95M -190.29M -119.11M
Comprehensive Income
-13.07M -21.7M 6.64M
Shareholders Equity
142.37M 197.04M 289.53M
Total Investments
33K 33K 33K